Nurse Practitioner, Family · Zanesville, OH
NPI
1871079392
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2951 Maple Ave
Zanesville, OH, 43701
Phone (740) 454-5644
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
398 services
Medicare patients, 2024
210
Average age 72
Drug cost, 2024
$1.6M
6,381 prescriptions
Company payments, 2025
$375
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joy Stashonsky was code 99214 (office e&m - established), 272 times for 162 patients. In total Joy Stashonsky billed 398 services in 6 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 272 | 162 | $56.32 | $15K |
| 99406 Behavioral Health Services | Facility | 66 | 45 | $9.28 | $612 |
| 99213 Office E&M - Established | Office | 36 | 36 | $58.57 | $2,109 |
| 99204 Office E&M - New | Facility | 15 | 15 | $73.94 | $1,109 |
By year: 2022 $12K for 279 services; 2023 $24K for 456 services; 2024 $20K for 398 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joy Stashonsky prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,238 prescriptions and refills. In total Joy Stashonsky wrote 6,381 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,238 | 1,301 | 334 | $39K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 771 | 833 | 133 | $533K |
| Montelukast Sodium Generic | 547 | 710 | 98 | $2,183 |
| Spiriva Respimat Tiotropium Bromide | 361 | 380 | 55 | $196K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 356 | 369 | 65 | $170K |
| Ventolin Hfa Albuterol Sulfate | 313 | 324 | 94 | $16K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 232 | 239 | 31 | $114K |
| Symbicort Budesonide/Formoterol Fumarate | 215 | 226 | 45 | $47K |
| Roflumilast Generic | 211 | 235 | 32 | $8,853 |
| Dulera Mometasone/Formoterol | 180 | 194 | 32 | $64K |
| Incruse Ellipta Umeclidinium Bromide | 174 | 176 | 35 | $60K |
| Fluticasone Propionate Generic | 173 | 299 | 61 | $2,183 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 162 | 164 | 37 | $26K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 143 | 163 | 31 | $15K |
| Prednisone Generic | 118 | 118 | 78 | $249 |
Brand drugs: 4,555 claims; generic drugs: 1,826 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joy Stashonsky $375 ($375 in general payments such as food, travel and fees) from 9 companies. The largest payer was GlaxoSmithKline, LLC. with $61.23.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 4 | $61.23 |
| Genzyme Corporation SNY | 3 | $58.87 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $51.83 |
| Viatris Specialty LLC | 2 | $45.58 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $38.77 |
| Philips North America LLC PHG | 2 | $38.11 |
| Insmed, Inc. INSM | 2 | $30.89 |
| Grifols USA, LLC | 1 | $25.68 |
| Lilly USA, LLC LLY | 1 | $23.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.